AustralianSuper’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.59M | Sell |
18,404
-197,958
| -91% | -$19M | 0.01% | 245 |
|
|
2025
Q4 | $20.8M | Buy |
216,362
+53,006
| +32% | +$5.15M | 0.1% | 145 |
|
|
2025
Q3 | $15.6M | Buy |
+163,356
| New | +$15M | 0.07% | 158 |
|
|
2024
Q4 | – | Sell |
-46,648
| Closed | -$4.2M | – | 244 |
|
|
2024
Q3 | $4.2M | Sell |
46,648
-28,304
| -38% | -$2.38M | 0.02% | 156 |
|
|
2024
Q2 | $5.9M | Buy |
74,952
+3,307
| +5% | +$271K | 0.03% | 138 |
|
|
2024
Q1 | $6.23M | Hold |
71,645
| – | – | 0.04% | 139 |
|
|
2023
Q4 | $5.9M | Hold |
71,645
| – | – | 0.04% | 156 |
|
|
2023
Q3 | $5.61M | Buy |
71,645
+3,536
| +5% | +$296K | 0.04% | 138 |
|
|
2023
Q2 | $6M | Sell |
68,109
-801,050
| -92% | -$69M | 0.04% | 160 |
|
|
2023
Q1 | $70.1M | Hold |
869,159
| – | – | 0.43% | 61 |
|
|
2022
Q4 | $68M | Buy |
869,159
+9,636
| +1% | +$781K | 0.45% | 61 |
|
|
2022
Q3 | $69.4K | Buy |
859,523
+795,253
| +1,237% | +$71.5M | 0.49% | 54 |
|
|
2022
Q2 | $5.77K | Sell |
64,270
-248,354
| -79% | -$25.2M | 0.04% | 170 |
|
|
2022
Q1 | $34.7K | Buy |
312,624
+147,692
| +90% | +$15.6M | 0.19% | 87 |
|
|
2021
Q4 | $17.5K | Sell |
164,932
-44,090
| -21% | -$5.11M | 0.09% | 132 |
|
|
2021
Q3 | $26.2M | Sell |
209,022
-40,563
| -16% | -$5.25M | 0.17% | 90 |
|
|
2021
Q2 | $31M | Buy |
249,585
+206
| +0.1% | +$25.9K | 0.22% | 72 |
|
|
2021
Q1 | $29.5M | Sell |
249,379
-876,752
| -78% | -$103M | 0.23% | 73 |
|
|
2020
Q4 | $132M | Buy |
1,126,131
+16,427
| +1% | +$1.81M | 0.99% | 40 |
|
|
2020
Q3 | $115M | Buy |
1,109,704
+183,950
| +20% | +$18.5M | 0.98% | 41 |
|
|
2020
Q2 | $84.9M | Buy |
925,754
+81,556
| +10% | +$7.82M | 0.82% | 41 |
|
|
2020
Q1 | $76.1M | Buy |
844,198
+187,754
| +29% | +$20M | 0.98% | 35 |
|
|
2019
Q4 | $74.5M | Sell |
656,444
-17,434
| -3% | -$1.91M | 0.63% | 43 |
|
|
2019
Q3 | $73.2M | Buy |
673,878
+167,409
| +33% | +$17.5M | 0.69% | 40 |
|
|
2019
Q2 | $49.3M | Buy |
506,469
+40,734
| +9% | +$3.72M | 0.47% | 49 |
|
|
2019
Q1 | $42.4M | Buy |
465,735
+346,234
| +290% | +$31M | 0.44% | 50 |
|
|
2018
Q4 | $10.9M | Buy |
119,501
+77,301
| +183% | +$7.22M | 0.17% | 52 |
|
|
2018
Q3 | $4.15M | Buy |
42,200
+10,200
| +32% | +$943K | 0.08% | 52 |
|
|
2018
Q2 | $2.74M | Sell |
32,000
-251,000
| -89% | -$21M | 0.06% | 54 |
|
|
2018
Q1 | $22.7M | Hold |
283,000
| – | – | 0.72% | 28 |
|
|
2017
Q4 | $22.9M | Buy |
+283,000
| New | +$22.7M | 0.83% | 32 |
|
|
2017
Q2 | – | Sell |
-289,600
| Closed | -$23.3M | – | 30 |
|
|
2017
Q1 | $23.3M | Buy |
+289,600
| New | +$22.6M | 2.67% | 19 |
|
Other funds holding MDT
VCM
VPM
AustralianSuper's MDT Position: Q1 2026 in Review
AustralianSuper reduced its Medtronic (MDT) stake by 91% in Q1 2026, selling an estimated $19M and leaving 18,404 shares worth $1.59M. The position accounts for 0.01% of the portfolio, ranked #245.
AustralianSuper first reported a position in MDT in Q1 2017 and has held it in 32 quarters since. The position peaked at $132M in Q4 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- AustralianSuper held 18,404 shares of Medtronic worth $1.59M as of Q1 2026.
- AustralianSuper sold 197,958 Medtronic shares in Q1 2026, an estimated $19M.
- Medtronic made up 0.01% of AustralianSuper's portfolio in Q1 2026, its #245 holding.
- AustralianSuper first reported a position in Medtronic in Q1 2017 and has held it in 32 quarters since.
- AustralianSuper's Medtronic position peaked at $132M in Q4 2020.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on AustralianSuper's 13F filing for Q1 2026, filed 7 May 2026.